Key result
The Framingham-Simplified model showed acceptable 10-year CVD discrimination in women and men, though it underestimated risk in women.
Why the study?
The predictive performance of the Framingham-SP model, which replaces lipids with BMI to eliminate laboratory testing, was unknown in Canada.
Does the nonlaboratory Framingham-Simplified (Framingham-SP) risk model accurately discriminate and calibrate 10-year cardiovascular disease risk in a Canadian adult primary prevention cohort?
Cohort (n=7,363)
Yes
Does the nonlaboratory Framingham-Simplified (Framingham-SP) risk model accurately discriminate and calibrate 10-year cardiovascular disease risk in a Canadian adult primary prevention cohort?
First Canadian external validation showing that the nonlaboratory BMI-based Framingham-Simplified model provides acceptable 10-year CVD discrimination in both sexes and good calibration in men, supporting its use for preliminary risk screening in nonclinical settings while highlighting risk underestimation in women.
Answers are grounded in this paper and cite their sources.
Supports preliminary screening in Canadian men; extends validation but leaves open recalibration needs in women.
Background: The Framingham risk model is recommended for estimating 10-year cardiovascular disease (CVD) risk in Canada. Its simplified version (Framingham-SP) replaces lipids with body mass index, eliminating the need for laboratory testing. The predictive performance of the Framingham-SP in Canada is unknown. This external validation study assessed the discrimination and calibration of the Framingham-SP model in a prospective cohort from Quebec, Canada. Methods: The study sample included 3692 women and 3671 men free of CVD at baseline (1999-2001; follow-up until 2011). Incident CVD events were identified using medico-administrative databases. Multiple imputation was used to handle missing data. Discrimination was assessed using C-statistics. Calibration was evaluated using calibration-in-the-large, absolute difference, and discordance. Results: Over the 10-year follow-up, 211 CVD events occurred among women and 453 occurred among men. For women, the predicted 10-year CVD risk was 4.07% (95% confidence interval [CI]: 3.94-4.20), and the observed risk was 5.72% (95% CI: 5.01-6.51). The C-statistic was 0.72 (95% CI: 0.68-0.76). For men, the predicted risk was 11.73% (95% CI: 11.44-12.02), and the observed risk was 12.34% (95% CI: 11.32-13.44). The C-statistic was 0.72 (95% CI: 0.69-0.74). Overall, calibration was lower among women, particularly those in intermediate and high predicted risk categories. Conclusions: The Framingham-SP model demonstrated acceptable predictive performance in this Canadian cohort. Its simplified format may help support preliminary CVD risk assessment and lifestyle counselling, including in nonclinical settings, while remaining complementary to guideline-based clinical evaluation. Recalibration may improve performance among high-risk women.
No takes yet. Share an insight, caveat, or question.
Garcon et al. (2026) conducted a cohort in Primary prevention of cardiovascular disease (adults free of CVD at baseline) (n=7,363). Framingham-Simplified (Framingham-SP) 10-year cardiovascular disease risk prediction model (substituting BMI for lipid levels) vs. Observed 10-year cumulative incidence of cardiovascular disease events was evaluated on 10-year incidence of a first major cardiovascular disease event (composite of coronary heart disease, stroke or transient ischemic attack, congestive heart failure, peripheral artery disease, or cardiovascular death) (C-statistic 0.72 in women and 0.72 in men, 95% CI 0.68-0.76 (women); 0.70-0.74 (men)). The Framingham-Simplified model showed acceptable 10-year CVD discrimination in women and men, though it underestimated risk in women.
Synapse has enriched 10 related papers. Consider them for comparative context: